Takeda Acquires Celiac Venture PvP For Up To $330m

 
• By Ian Haydock

Japanese firm exercises option after promising Phase I results in disorder with no approved drugs, in deal that builds out its celiac pipeline.

Abdominal pain of a young woman. Taken from the front view on a white background. Abdominal pain Menstrual pain of women
Deal Brings Celiac Asset To Takeda • Source: Shutterstock

More from Japan

More from Focus On Asia